Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus
Helena Tydén(Lund University), AA Bengtsson(Lund University), Lennart Truedsson(Lund University), Ola Nived(Lund University), Tomas Leanderson(Lund University), Andreas Jönsen(Lund University), B. Gullstrand(Lund University), Christian Lood(University of Washington), G Sturfelt(Lund University), Fredrik Ivars(Lund University)
Cited by 90
Related Papers
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
|Nature Immunology|2003|363
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
|PLoS Biology|2009|358
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
|The Journal of Immunology|2007|246
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
|Journal of Clinical Investigation|2018|230
IFN-β Gene Deletion Leads to Augmented and Chronic Demyelinating Experimental Autoimmune Encephalomyelitis
|The Journal of Immunology|2003|201